BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37851285)

  • 21. The impact of bariatric surgery on insulin-treated type 2 diabetes patients.
    Lemus R; Karni D; Hong D; Gmora S; Breau R; Anvari M
    Surg Endosc; 2018 Feb; 32(2):990-1001. PubMed ID: 28842774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should metabolic surgery be offered in morbidly obese patients with type I diabetes?
    Robert M; Belanger P; Hould FS; Marceau S; Tchernof A; Biertho L
    Surg Obes Relat Dis; 2015; 11(4):798-805. PubMed ID: 25868828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline neutrophil-to-lymphocyte ratio is associated with long-term T2D remission after metabolic surgery.
    Bonaventura A; Liberale L; Carbone F; Vecchié A; Bonomi A; Scopinaro N; Camerini GB; Papadia FS; Maggi D; Cordera R; Dallegri F; Adami G; Montecucco F
    Acta Diabetol; 2019 Jul; 56(7):741-748. PubMed ID: 30993529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of type 2 diabetes remission after metabolic surgery: a comparison of the individualized metabolic surgery score and the ABCD score.
    Chen JC; Hsu NY; Lee WJ; Chen SC; Ser KH; Lee YC
    Surg Obes Relat Dis; 2018 May; 14(5):640-645. PubMed ID: 29526672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weight-loss Independent Clinical and Metabolic Biomarkers Associated with Type 2 Diabetes Remission Post-bariatric/metabolic Surgery.
    Chaiyasoot K; Sakai NS; Zakeri R; Makaronidis J; Crisóstomo L; Alves MG; Gan W; Firman C; Jassil FC; Hall-Craggs MA; Taylor SA; Batterham RL
    Obes Surg; 2023 Dec; 33(12):3988-3998. PubMed ID: 37910328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the individualized metabolic surgery score for bariatric procedure selection in the merged data of two randomized clinical trials (SLEEVEPASS and SM-BOSS).
    Saarinen I; Grönroos S; Hurme S; Peterli R; Helmiö M; Bueter M; Strandberg M; Wölnerhanssen BK; Salminen P
    Surg Obes Relat Dis; 2023 May; 19(5):522-529. PubMed ID: 36503734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the evidence for metabolic surgery for type 2 diabetes? A critical perspective.
    Amouyal C; Andreelli F
    Diabetes Metab; 2017 Feb; 43(1):9-17. PubMed ID: 27400671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of diabetes remission after bariatic surgery may be jeopardized by remission criteria and previous hypoglycemic treatment.
    Ramos-Levi A; Sanchez-Pernaute A; Matia P; Cabrerizo L; Barabash A; Hernandez C; Calle-Pascual A; Torres A; Rubio M
    Obes Surg; 2013 Oct; 23(10):1520-6. PubMed ID: 23702908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventive effect of bariatric surgery on type 2 diabetes onset in morbidly obese inpatients: a national French survey between 2008 and 2016 on 328,509 morbidly obese patients.
    Bailly L; Schiavo L; Sebastianelli L; Fabre R; Morisot A; Pradier C; Iannelli A
    Surg Obes Relat Dis; 2019 Mar; 15(3):478-487. PubMed ID: 30745152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy in type 2 diabetes mellitus remission in patients undergoing bariatric surgery.
    Pereyra-García Castro FM; Oliva García JG; García Nuñez MA; García Bray BF; Suarez Llanos JP; Moneva Arce ME; Palacio Abizanda JE
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Jan; 66(1):56-61. PubMed ID: 30392998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early continuous glucose monitoring for predicting remission of type 2 diabetes 1 year after bariatric surgery.
    Turquetil A; Morello R; Joubert M; Le Roux Y; Reznik Y
    Diabetes Metab; 2021 Nov; 47(6):101255. PubMed ID: 33991661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Good Glycemic Outcomes Following Bariatric Surgery Among Patients With Type 2 Diabetes, Obesity, and Low-Titer GAD Antibodies.
    Kaur R; Kim D; Cutfield R; Booth M; Plank L; Murphy R
    Diabetes Care; 2021 Feb; 44(2):607-609. PubMed ID: 33310883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five-Year Changes in Weight and Diabetes Status After Bariatric Surgery for Craniopharyngioma-Related Hypothalamic Obesity: a Case-Control Study.
    Faucher P; Carette C; Jannot AS; Gatta-Cherifi B; Van Straaten A; Piquet MA; Raverot G; Alligier M; Batisse T; Ziegler O; Drui D; Bretault M; Farigon N; Slim K; Genser L; Poghosyan T; Vychnevskaia K; Blanchard C; Robert M; Gronnier C; Poitou C; Czernichow S
    Obes Surg; 2022 Jul; 32(7):2321-2331. PubMed ID: 35524022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Effectiveness Evaluation of Bariatric Surgery for Morbidly Obese with Diabetes Patients in Thailand.
    Viratanapanu I; Romyen C; Chaivanijchaya K; Sornphiphatphong S; Kattipatanapong W; Techagumpuch A; Kitisin K; Pungpapong SU; Tharavej C; Navicharern P; Boonchayaanant P; Udomsawaengsup S
    J Obes; 2019; 2019():5383478. PubMed ID: 30863633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis.
    Panunzi S; De Gaetano A; Carnicelli A; Mingrone G
    Ann Surg; 2015 Mar; 261(3):459-67. PubMed ID: 25361217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic agents in the context of metabolic/bariatric surgery: expanding the scope and impact of diabetes drug discovery.
    Janero DR
    Expert Opin Drug Discov; 2014 Mar; 9(3):221-8. PubMed ID: 24397872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bariatric surgery is expensive but improves co-morbidity: 5-year assessment of patients with obesity and type 2 diabetes.
    Wu T; Wong SKH; Law BTT; Grieve E; Wu O; Tong DKH; Leung DKW; Ng EKW; Lam CLK; Wong CKH
    Br J Surg; 2021 May; 108(5):554-565. PubMed ID: 34043776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of the DiaRem Score for Predicting Diabetes Remission in Two Health Systems Following Bariatric Surgery Procedures in Hispanic and non-Hispanic White Patients.
    Craig Wood G; Horwitz D; Still CD; Mirshahi T; Benotti P; Parikh M; Hirsch AG
    Obes Surg; 2018 Jan; 28(1):61-68. PubMed ID: 28717860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative insulin therapy as a marker for type 2 diabetes remission in obese patients after bariatric surgery.
    Hariri K; Guevara D; Jayaram A; Kini SU; Herron DM; Fernandez-Ranvier G
    Surg Obes Relat Dis; 2018 Mar; 14(3):332-337. PubMed ID: 29339030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which criteria should be used to define type 2 diabetes remission after bariatric surgery?
    Ramos-Levi AM; Cabrerizo L; Matía P; Sánchez-Pernaute A; Torres AJ; Rubio MA
    BMC Surg; 2013 Mar; 13():8. PubMed ID: 23537494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.